https://www.mayoclinic.org/tests-procedures/breast-biopsy/about/pac-20384812

Throughout the entire process of breast needle biopsy, quality control and safety standards for the needle core are fundamental to ensuring diagnostic accuracy and preventing complications. Every stage, from manufacturing to clinical use, must adhere to strict international standards and operating procedures.

Manufacturing End: Rigorous Challenges for Materials and Processes

The production of high-quality needle cores begins with rigorous selection of raw materials. Medical-grade stainless steel, titanium alloy, or polymer must comply with ISO 10993 biocompatibility standards to ensure non-cytotoxicity and non-sensitization. During manufacturing, the cutting edge of the needle core must achieve micron-level sharpness to ensure smooth, tear-free tissue incisions. The inner surface of the sampling groove should undergo electrolytic polishing or special coating treatment to minimize tissue adhesion and friction. All finished products must pass simulated puncture testing to verify consistent penetration force profiles, sample volume accuracy, and smooth retraction within standard gel blocks. Additionally, packaging integrity and sterilization shelf life-typically achieved through ethylene oxide or gamma irradiation-are key components of final quality inspection.

Clinical End: Standardized Procedures and Complication Prevention

In clinical practice, the correct selection and use of needle cores are essential for safety. Physicians should choose appropriate needle core specifications and lengths based on lesion size, location, and the patient's coagulation function. Prior to the procedure, strict skin disinfection and local anesthesia must be performed, and the needle tip position should be repeatedly confirmed under imaging guidance. To prevent complications such as pneumothorax (when lesions are close to the chest wall), hematoma, or infection, the "fast insertion, slow withdrawal" principle should be followed, and the puncture site should be firmly compressed for at least 5 minutes after needle removal. For institutions using reusable needle cores, a comprehensive process for cleaning, disinfection, sterilization, and functional inspection must be established, with detailed records kept of each use. Any needle core showing dullness or deformation of the cutting edge should be immediately discarded.

Regulations and Standards: Compliance Requirements in a Global Context

Regulatory oversight for biopsy needle cores is extremely stringent in major global markets. In China, needle cores are classified as Class III medical devices and must undergo registration approval by the National Medical Products Administration (NMPA), requiring submission of a complete set of documentation including product technical requirements, biocompatibility reports, and clinical trial data (if applicable). In the United States, the FDA classifies them as either Class II or Class III devices, necessitating premarket notification via 510(k) or premarket approval (PMA). The European Union requires CE certification under the MDR regulations. Manufacturers must also establish comprehensive adverse event reporting systems, with any incidents related to needle core breakage, detachment, tissue burns, or similar events required to be reported within specified timeframes.

Future Direction: From Passive Compliance to Proactive Safety

As technology advances, safety standards are continuously evolving. For example, new-generation smart needle cores can integrate pressure sensors that automatically trigger an alarm when puncture resistance abnormally increases-indicating a possible penetration into a blood vessel or pleura. Disposable needle core designs that prevent reuse (such as self-destruct mechanisms) are also becoming increasingly widespread. In addition, industry associations and academic organizations regularly issue guidelines emphasizing the use of certified non-ferromagnetic needle cores in MRI environments to avoid the "missile effect," where the needle core is pulled into the strong magnetic field. Ultimately, only by combining manufacturers' lean production practices, physicians' expert skills, and stringent oversight from regulatory bodies can every breast biopsy needle core be ensured to serve patients safely and effectively.